These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1796038)

  • 1. Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme.
    Franssen EJ; van Amsterdam RG; Visser J; Moolenaar F; de Zeeuw D; Meijer DK
    Pharm Res; 1991 Oct; 8(10):1223-30. PubMed ID: 1796038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight proteins as carriers for renal drug targeting: naproxen coupled to lysozyme via the spacer L-lactic acid.
    Franssen EJ; Moolenaar F; de Zeeuw D; Meijer DK
    Pharm Res; 1993 Jul; 10(7):963-9. PubMed ID: 8378258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates.
    Franssen EJ; Koiter J; Kuipers CA; Bruins AP; Moolenaar F; de Zeeuw D; Kruizinga WH; Kellogg RM; Meijer DK
    J Med Chem; 1992 Apr; 35(7):1246-59. PubMed ID: 1560438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of naproxen covalently linked to HSA to sinusoidal cell types of the liver.
    Melgert BN; Wartna E; Lebbe C; Albrecht C; Molema G; Poelstra K; Reichen J; Meijer DK
    J Drug Target; 1998; 5(5):329-42. PubMed ID: 9771615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules.
    Franssen EJ; Jansen RW; Vaalburg M; Meijer DK
    Biochem Pharmacol; 1993 Mar; 45(6):1215-26. PubMed ID: 8466542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-targeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in vivo.
    Haas M; Kluppel AC; Wartna ES; Moolenaar F; Meijer DK; de Jong PE; de Zeeuw D
    Kidney Int; 1997 Dec; 52(6):1693-9. PubMed ID: 9407519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal targeting of a non-steroidal anti-inflammatory drug: effects on renal prostaglandin synthesis in the rat.
    Haas M; Moolenaar F; Meijer DK; de Jong PE; de Zeeuw D
    Clin Sci (Lond); 1998 Nov; 95(5):603-9. PubMed ID: 9791047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic bile duct obstruction and LPS upon targeting of naproxen to the liver using naproxen-albumin conjugate.
    Albrecht C; Melgert BN; Reichen J; Poelstra K; Meijer DK
    J Drug Target; 1998; 6(2):105-17. PubMed ID: 9886235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting naproxen coupled to human serum albumin to nonparenchymal cells reduces endotoxin-induced mortality in rats with biliary cirrhosis.
    Albrecht C; Meijer DK; Lebbe C; Sägesser H; Melgert BN; Poelstra K; Reichen J
    Hepatology; 1997 Dec; 26(6):1553-9. PubMed ID: 9397997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between naproxen, naproxen-protein conjugates, and naproxen-lysine in plasma via micellar electrokinetic capillary chromatography--a new approach in the bioanalysis of drug targeting preparations.
    Albrecht C; Reichen J; Visser J; Meijer DK; Thormann W
    Clin Chem; 1997 Nov; 43(11):2083-90. PubMed ID: 9365392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific delivery of captopril to the kidney with the prodrug captopril-lysozyme.
    Kok RJ; Grijpstra F; Walthuis RB; Moolenaar F; de Zeeuw D; Meijer DK
    J Pharmacol Exp Ther; 1999 Jan; 288(1):281-5. PubMed ID: 9862782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentials and limitations of the low-molecular-weight protein lysozyme as a carrier for renal drug targeting.
    Haverdings RF; Haas M; Greupink AR; de Vries PA; Moolenaar F; de Zeeuw D; Meijer DK
    Ren Fail; 2001; 23(3-4):397-409. PubMed ID: 11499555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery to the kidneys and the bladder with the low molecular weight protein lysozyme.
    Kok RJ; Haas M; Moolenaar F; de Zeeuw D; Meijer DK
    Ren Fail; 1998 Mar; 20(2):211-7. PubMed ID: 9574445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugation of desmethylnaproxen in the rat--a novel acyl glucuronide-sulfate diconjugate as a major biliary metabolite.
    Jaggi R; Addison RS; King AR; Suthers BD; Dickinson RG
    Drug Metab Dispos; 2002 Feb; 30(2):161-6. PubMed ID: 11792685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of captopril to the kidney reduces renal angiotensin-converting enzyme activity without affecting systemic blood pressure.
    Kok RJ; Haverdings RF; Grijpstra F; Koiter J; Moolenaar F; de Zeeuw D; Meijer DK
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1139-43. PubMed ID: 12023548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of naproxen.
    Davies NM; Anderson KE
    Clin Pharmacokinet; 1997 Apr; 32(4):268-93. PubMed ID: 9113437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel brain targeting prodrugs of naproxen based on dimethylamino group with various linkages.
    Zhang Q; Liang Z; Chen LY; Sun X; Gong T; Zhang ZR
    Arzneimittelforschung; 2012 Jun; 62(6):261-6. PubMed ID: 22407924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of doxorubicin to the urinary bladder of the rat shows increased cytotoxicity in the bladder urine combined with an absence of renal toxicity.
    Haas M; Moolenaar F; Elsinga A; Van der Wouden EA; de Jong PE; Meijer DK; de Zeeuw D
    J Drug Target; 2002 Feb; 10(1):81-9. PubMed ID: 11996090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans. Effect of cimetidine.
    Vree TB; Van Den Biggelaar-Martea M; Verwey-Van Wissen CP; Vree ML; Guelen PJ
    Br J Clin Pharmacol; 1993 May; 35(5):467-72. PubMed ID: 8512758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.